Not enough evidence to prove plasma therapy works: ICMR scientist Dr Samiran Panda
The Centre on Monday revised the clinical guidance for Covid-19 treatment, dropping the off-label use of convalescent plasma from the treatment protocol for adult patients. The development came after a meeting of the ICMR-National Task Force for Covid-19 wherein all members voted in favour of removing the use of convalescent plasma from the guidelines.
Dr Samiran Panda, Indian Council of Medical Research (ICMR) scientist who was also a part of the panel that dropped plasma therapy from Covid-19 management guidelines, told India Today that the decision was taken since anecdotal evidence was very weak, and added that it was not helping patients but only resulting in panic
Dr Samiran Panda, Indian Council of Medical Research (ICMR) scientist who was also a part of the panel that dropped plasma therapy from Covid-19 management guidelines, told India Today that the decision was taken since anecdotal evidence was very weak, and added that it was not helping patients but only resulting in panic